You should contact your GP or mental health team urgently if you experience any of the following whilst taking Mounjaro: Significant changes in mood (either elevated or depressed) Increased anxiety or agitation Changes in sleep patterns (insomnia or excessive sleeping) Thoughts of self-harm or suicide (if at immediate risk, call 999 or go to A&E) Severe or persistent gastrointestinal symptoms affecting your ability to eat or take medications Signs of dehydration Symptoms of hypoglycaemia if also taking insulin or sulfonylureas (shakiness, sweating, confusion) Additionally, seek medical advice if you notice any unusual physical symptoms such as: Severe abdominal pain Persistent vomiting Signs of pancreatitis (severe upper abdominal pain radiating to the back) Symptoms of gallbladder disease (pain in the right upper abdomen, fever, jaundice) Symptoms of thyroid problems (lump in the neck, hoarseness, difficulty swallowing) Changes in vision, particularly if you have diabetic retinopathy While rare, these require prompt medical assessment

Researchers buy Tirzepatide because it is the first peptide to switch on two gut-hormone receptors at once GLP-1 and GIP
Uncropped images of key gels are presented in Supplementary Fig
GLP-1 travels to the brain and influences the appetite centres, promoting satiety and reducing hunger
Gold PW, Goodwin FK, Chrousos GP